A detailed history of James Hambro & Partners transactions in Mckesson Corp stock. As of the latest transaction made, James Hambro & Partners holds 120,915 shares of MCK stock, worth $102 Million. This represents 3.85% of its overall portfolio holdings.

Number of Shares
120,915
Holding current value
$102 Million
% of portfolio
3.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$738.06 - $859.37 $89.2 Million - $104 Million
120,915 New
120,915 $102 Million
Q2 2018

Jul 12, 2018

BUY
$133.4 - $158.13 $68,567 - $81,278
514 Added 141.6%
877 $117,000
Q1 2018

Apr 30, 2018

BUY
$138.75 - $176.72 $20,535 - $26,154
148 Added 68.84%
363 $51,000
Q4 2017

Feb 13, 2018

BUY
$135.02 - $162.6 $29,029 - $34,959
215
215 $34,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $121B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track James Hambro & Partners Portfolio

Follow James Hambro & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

News

Stay updated on James Hambro & Partners with notifications on news.